Nuo Therapeutics Inc (AURX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nuo Therapeutics Inc (AURX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7478
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company’s flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient’s innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has its facilities in Nashville, Tennessee; and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc (AURX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nuo Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Aldagen Raises Additional US$0.06 Million In Venture Financing 10
Partnerships 11
Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11
Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12
Nuo Therapeutics Amends Licensing Agreement with Arthrex 13
Equity Offering 14
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 19
Cytomedix Completes Private Placement Of Shares For US$7 Million 20
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 21
Acquisition 22
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22
Nuo Therapeutics Inc – Key Competitors 24
Nuo Therapeutics Inc – Key Employees 25
Nuo Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Legal and Regulatory 27
Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Nuo Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Aldagen Raises Additional US$0.06 Million In Venture Financing 10
Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11
Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12
Nuo Therapeutics Amends Licensing Agreement with Arthrex 13
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18
Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 19
Cytomedix Completes Private Placement Of Shares For US$7 Million 20
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 21
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22
Nuo Therapeutics Inc, Key Competitors 24
Nuo Therapeutics Inc, Key Employees 25
Nuo Therapeutics Inc, Other Locations 26
Nuo Therapeutics Inc, Subsidiaries 26

List of Figures
Nuo Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nuo Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nuo Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Nuo Therapeutics Inc (AURX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Watsco, Inc.:企業の戦略・SWOT・財務分析
    Watsco, Inc. - Strategy, SWOT and Corporate Finance Report Summary Watsco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Microsemi Corporation (MSCC):企業の財務・戦略的SWOT分析
    Microsemi Corporation (MSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Home Depot, Inc.:企業のM&A・事業提携・投資動向
    The Home Depot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Home Depot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Active Motif Inc:医療機器:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Leonardo S.p.A.:企業のM&A・事業提携・投資動向
    Leonardo S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leonardo S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Pharmaxis Ltd (PXS)-医療機器分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • Option Care Health Inc (OPCH):企業の財務・戦略的SWOT分析
    Option Care Health Inc (OPCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Celularity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celularity Inc (Celularity) is a biotechnology company that develops and commercializes therapeutics derived from the placenta for autoimmune and degenerative diseases, immuno-oncology, and functional regeneration. The company’s pre-clinical and clinical assets include CAR-T cell receptor an …
  • Biohaven Pharmaceutical Holding Company Ltd (BHVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Biohaven Pharmaceutical Holding Company Ltd (Biohaven), a subsidiary of Portage Biotech Inc, is a clinical-stage biopharmaceutical company that develops late-stage product candidates for neurological diseases. The company develops small molecule CGRP receptor antagonist platform that include …
  • Tulip Star Hotels Limited:企業の戦略・SWOT・財務分析
    Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dine Brands Global, Inc. (DIN):企業の財務・戦略的SWOT分析
    Dine Brands Global, Inc. (DIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • China General Plastics Corp (1305):企業の財務・戦略的SWOT分析
    Summary China General Plastics Corp (CGPC), a subsidiary of USI Group is a chemical company that manufactures PVC resins. The company's products include poly vinyl chloride resins, raw materials, vinyl films, films and sheet products, construction products, leather products, and house ware products. …
  • Urenco Ltd:企業の戦略・SWOT・財務情報
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kudelski SA (KUD):企業の財務・戦略的SWOT分析
    Kudelski SA (KUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Strongbridge Biopharma plc (SBBP)-製薬・医療分野:企業M&A・提携分析
    Summary Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokale …
  • Vivid Technology Ltd (VIV):電力:M&Aディール及び事業提携情報
    Summary Vivid Technology Ltd (Vivid Technology), formerly Greenearth Energy Ltd, is a renewable energy company that offers technology services. The company provides geothermal exploration and investment services. It provides services such as custom installation, project management, and lighting effi …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Ariel Corp:企業の戦略的SWOT分析
    Ariel Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆